Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center, Real-world Study of Shenbailing Granules in Patients After Breast Cancer Surgery

NCT06881550 is registered in ClinicalTrials.gov with Caigang Liu as lead sponsor.

NCT NCT06881550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06881550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center, Real-world Study of Shenbailing Granules in Patients After Breast Cancer Surgery
Lead sponsor
Caigang Liu
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
December 30, 2024
Completion date
December 10, 2026
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer